Evidence map›Paper›PMID 39126317›Full record

ArticleNucleic acids research2024

DNA damage-induced phosphorylation of a replicative DNA helicase results in inhibition of DNA replication through attenuation of helicase function.

Caleb Homiski, Rama Dey-Rao, Shichen Shen, Jun Qu, Thomas Melendy

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Caleb HomiskiDepartments of Microbiology & Immunology and Biochemistry, and the Witebsky Center for Microbial Pathogenesis & Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York at Buffalo, Buffalo, NY 14203, USA.
Rama Dey-RaoDepartments of Microbiology & Immunology and Biochemistry, and the Witebsky Center for Microbial Pathogenesis & Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York at Buffalo, Buffalo, NY 14203, USA.
Shichen ShenDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York at Buffalo, Buffalo, NY 14203, USA; NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA.
Jun QuDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York at Buffalo, Buffalo, NY 14203, USA; NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA.
Thomas MelendyDepartments of Microbiology & Immunology and Biochemistry, and the Witebsky Center for Microbial Pathogenesis & Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York at Buffalo, Buffalo, NY 14203, USA.ORCID 0000-0003-1558-6262

Funding

TRAINING IN MICROBIAL PATHOGENESIST32AI007614 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI READ, LAURIE K. · 1999 to 2015
$2.1M
Evaluation and development of E1-TopoI as a target for anti-HPV therapeuticsR01AI095632 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MELENDY, THOMAS · 2012 to 2015
$1.6M
MECHANISMS OF DNA DAMAGE TRIGGERED S PHASE CHECKPOINTSR01CA089259 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MELENDY, THOMAS · 2001 to 2005
$1.4M
Slowing of the polyomavirus DNA replication fork in response to DDRR21AI164081 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MELENDY, THOMAS · 2021 to 2022
$439k
A novel DNA damage response that inhibits polyomavirus DNA replicationR21AI128421 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MELENDY, THOMAS · 2017 to 2018
$436k
NCI NIH HHS R01 CA089259NIAID NIH HHS R01 AI095632NIAID NIH HHS R21 AI128421NIAID NIH HHS R21 AI164081NIAID NIH HHS T32 AI007614NIH HHS AI16408101
6 · The paper itself

Abstract

A major function of the DNA damage responses (DDRs) that act during the replicative phase of the cell cycle is to inhibit initiation and elongation of DNA replication. It has been shown that DNA replication of the polyomavirus, SV40, is inhibited and its replication fork is slowed by cellular DDR responses. The inhibition of SV40 DNA replication is associated with enhanced DDR kinase phosphorylation of SV40 Large T-antigen (LT), the viral DNA helicase. Mass spectroscopy was used to identify a novel highly conserved DDR kinase site, T518, on LT. In cell-based assays expression of a phosphomimetic form of LT at T518 (T518D) resulted in dramatically decreased levels of SV40 DNA replication, but LT-dependent transcriptional activation was unaffected. Purified WT and LT T518D were analyzed in vitro. In concordance with the cell-based data, reactions using SV40 LT-T518D, but not T518A, showed dramatic inhibition of SV40 DNA replication. A myriad of LT protein-protein interactions and LT's biochemical functions were unaffected by the LT T518D mutation; however, LT's DNA helicase activity was dramatically decreased on long, but not very short, DNA templates. These results suggest that DDR phosphorylation at T518 inhibits SV40 DNA replication by suppressing LT helicase activity.

Indexed as

DNA DamageDNA HelicasesDNA ReplicationSimian virus 40Antigens, Polyomavirus TransformingCell LineHumansPhosphorylationVirus ReplicationAntigens, Polyomavirus TransformingDNA Helicases

Identifiers

PMID39126317
PMCPMC11417368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.